CeQur® Announces Exciting Advancements: 2 Recent FDA Clearances and New Clinical Evidence to be Presented at ADA

Extended 7-Day Wear and 1-Unit Dosing Clearances, and Two ADA Posters Signal a New Standard for Mealtime Insulin Management HORW, Switzerland, June 4, 2026 /PRNewswire/ -- CeQur®, the company dedicated to simplifying mealtime insulin delivery for people living with diabetes, today...